GlycoMimetics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

GlycoMimetics Stock Summary

GlycoMimetics competes with Mineralys Therapeutics,, Foghorn Therapeutics, Inventiva, Dyne Therapeutics, and Trevi Therapeutics. GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland. Glycomimetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.

GlycoMimetics Key Financial Ratios

GlycoMimetics Key Balance Sheet Accounts

GlycoMimetics Key Cash Accounts

GlycoMimetics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining GlycoMimetics's current stock value. Our valuation model uses many indicators to compare GlycoMimetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GlycoMimetics competition to find correlations between indicators driving GlycoMimetics's intrinsic value. More Info.GlycoMimetics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, GlycoMimetics' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GlycoMimetics' earnings, one of the primary drivers of an investment's value.

GlycoMimetics Systematic Risk

Today, most investors in GlycoMimetics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various GlycoMimetics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of GlycoMimetics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of GlycoMimetics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GlycoMimetics. We use our internally-developed statistical techniques to arrive at the intrinsic value of GlycoMimetics based on widely used predictive technical indicators. In general, we focus on analyzing GlycoMimetics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GlycoMimetics's daily price indicators and compare them against related drivers.

When running GlycoMimetics' price analysis, check to measure GlycoMimetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlycoMimetics is operating at the current time. Most of GlycoMimetics' value examination focuses on studying past and present price action to predict the probability of GlycoMimetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlycoMimetics' price. Additionally, you may evaluate how the addition of GlycoMimetics to your portfolios can decrease your overall portfolio volatility.